CA3277900A1 - Sel de s-oxprénolol - Google Patents

Sel de s-oxprénolol

Info

Publication number
CA3277900A1
CA3277900A1 CA3277900A CA3277900A CA3277900A1 CA 3277900 A1 CA3277900 A1 CA 3277900A1 CA 3277900 A CA3277900 A CA 3277900A CA 3277900 A CA3277900 A CA 3277900A CA 3277900 A1 CA3277900 A1 CA 3277900A1
Authority
CA
Canada
Prior art keywords
oxprenolol
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3277900A
Other languages
English (en)
Inventor
Melissa JOSEPH
Ronnie Maxwell Lawrence
Elaine MORTEN
Saurabh CHITRE
Natalie Louise KELK
Craig Callahan
Original Assignee
Actimed Therapeutics Ltd
Faraday Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actimed Therapeutics Ltd, Faraday Pharmaceuticals Inc filed Critical Actimed Therapeutics Ltd
Publication of CA3277900A1 publication Critical patent/CA3277900A1/fr
Pending legal-status Critical Current

Links

CA3277900A 2023-01-27 2024-01-26 Sel de s-oxprénolol Pending CA3277900A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2301180.2 2023-01-27

Publications (1)

Publication Number Publication Date
CA3277900A1 true CA3277900A1 (fr) 2024-08-02

Family

ID=

Similar Documents

Publication Publication Date Title
HUE071923T2 (hu) Az S-oxprenolol sói
CA3277900A1 (fr) Sel de s-oxprénolol
CA3300217A1 (fr) Polymorphe de sel de ribociclib
CA3266364A1 (fr) Utilisation d'un composé hétéroaryloxynaphtalène
CA3292360A1 (fr) Utilisation de micro-peptide miac
HK40104221A (en) Advantageous morphic form of at-527 hemi-sulfate salt
EP4151639A4 (fr) Sel cristallin d'éribuline
AU2023902842A0 (en) Methods of inhibiting hGIIA
CA3268997A1 (fr) Formes à l'état solide de sels de cilofexor
EP4319743A4 (fr) Co-cristaux d'upadacitinib
TWI922473B (zh) 普拉替尼之固體形式
HK40114030A (en) Ulodesine salt
HK40115956A (en) Polymorphs of the hydrochloride salt of linaprazan glurate
CA3270514A1 (fr) Formes salines d'agents de dégradation d'irak4
HK40111295A (en) Crystalline forms of trofinetide
EP4240419A4 (fr) Intervention médiée par l'arnsi-nanobol contre la covid-19
CA3289184A1 (fr) Inhibiteurs hétéroarylindoles d'apol-1
HK40106921A (zh) Mazdutide的应用
HK40091795A (en) Use of 5-nitro-8-hydroxyquinoline
HK40104204A (en) Solid forms of alpha-1062 gluconate
CA3279378A1 (fr) Polymorphes de sel de bromhydrate de linaprazan glurate
CA3288524A1 (fr) Formes cristallines d'événamide
HK40101096A (en) Salt crystals
CA3303749A1 (fr) Formes à l'état solide de samuraciclib
CA3299990A1 (fr) Formes à l'état solide de gusacitinib